Brinter: The Implant Your Body Grows Into

Synthetic implants have always been foreign objects the body learns to tolerate. Brinter is building 3D bioprinted tissue implants that the body absorbs, replaces, and makes its own.

Photo source:

brinter.com

The Problem With Every Implant Ever Made

When a surgeon repairs a torn rotator cuff, a ruptured Achilles tendon, or a damaged ACL, the materials available have always carried the same fundamental limitation. They are synthetic. The body does not recognise them as tissue. It tolerates them, builds scar tissue around them, and sometimes rejects them entirely. Nearly half of all rotator cuff operations using conventional regenerative materials fail. Achilles tendon injuries take nine to twelve months to heal, even with the best available treatments. ACL repairs carry high re-injury rates and poor graft integration. The problem is not the surgery. It is what the surgery puts inside the body. Brinter is building a different answer.

3D Bioprinted Tissue That Works With the Body

Brinter's platform uses a patented 3D bioprinter to manufacture implants from bioactive materials that mimic the architecture of natural human tissue. The implants are bioresorbable, meaning they do not remain in the body permanently. Instead, they degrade gradually as the body's own healing process takes over, replacing the implant structure with new, functional tissue. The printed architecture guides cell growth and vascularisation, signalling the body to regenerate rather than simply scar. The result is an implant designed not to be tolerated but to disappear, leaving behind real tissue in its place.

Personalised Down to the Cell

What separates Brinter's approach from conventional implant manufacturing is the depth of personalisation the platform enables. At the design level, each implant is sized and shaped precisely to fit the individual patient's anatomy. At the biological level, proteins, peptides, and signalling molecules can be customised to match each patient's specific healing profile. At the cellular level, a patient's own stem cells can be incorporated directly into the implant before surgery, boosting regeneration, improving integration, and reducing the risk that the body will respond to the implant as a foreign object. Three layers of personalisation, from geometry to biology to cells, applied to a single device printed for a single patient.

Orthopedic and Aesthetic Applications

The first target application is rotator cuff repair, where Brinter's implant is on track to become the world's first 3D bioprinted orthopedic implant to reach commercial use. Beyond orthopedics, the platform extends into aesthetic and reconstructive surgery. Bioprinted breast implants guide natural tissue regeneration as an alternative to permanent synthetic devices. Nasal implants mimic cartilage structure to support functional facial reconstruction. Urogenital implants support improved outcomes in reconstructive procedures that currently have very limited options.

Lock

You have exceeded your free limits for viewing our premium content

Please subscribe to have unlimited access to our innovations.